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Abstract We previously identified a 42 kDa Ins(1,3,4,5)P
4
(InsP
4
) receptor protein (p42
IP4
) in brain membranes from
several species. Here the cDNA sequence of p42
IP4
was obtained
by PCR using degenerate primers derived from peptide sequences
of proteolytic fragments of the porcine protein and by subsequent
screening of a pig brain cDNA library. The derived peptide
sequence of 374 amino acids for porcine p42
IP4
is 45 amino acids
shorter at the C-terminus than centaurin-K from rat (84%
homology) and has a calculated molecular mass of 43 kDa. From
the InsP
4
binding activity present in brain tissue homogenate
about 25% is found in the cytosolic fraction and 75% associated
with microsomes. Both activities are due to p42
IP4
since (i) a
peptide-specific antiserum recognizing specifically p42
IP4
labels
the InsP
4
receptor protein in membranes and in the cytosol, (ii)
the antiserum immunoprecipitates both the membrane protein
and the cytosolic protein of 42 kDa, (iii) the InsP
4
binding
activity released by high salt or by alkaline extraction from
membranes is identified immunologically as the 42 kDa protein,
and (iv) the affinity for InsP
4
and specificity for various
inositolphosphates are similar for the membrane-associated and
for the soluble p42
IP4
. The functional importance of p42
IP4
is
highlighted by the identical affinity for InsP
4
and for phospha-
tidylinositol (3,4,5)P
3
(K
i
= 1.6 and 0.9 nM, respectively). Thus,
the InsP
4
receptor, apparently a peripheral membrane protein,
which exists also as a cytosolic protein can transfer the signals
mediated by InsP
4
or by PtdInsP
3
between membranes and
cytosolic compartment.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
We do not yet have clear evidence about the role of the
putative second-messenger inositol 1,3,4,5-tetrakisphosphate
(InsP
4
) a metabolite of the well-characterized second-messen-
ger inositol 1,4,5-trisphosphate (InsP
3
) which releases Ca
2
from intracellular stores [1,2]. Some physiological functions
of InsP
4
proposed so far are connected to cellular Ca
2
con-
trol. The diverse e¡ects attributed to InsP
4
, such as re-seques-
tration of Ca
2
into the internal stores [3], activation of Ca
2
release from stores [4], in£ux of Ca
2
into non-excitable cells
[5] or involvement in generation of cytosolic Ca
2
oscillations
[6] re£ect con£icting evidence for the site of action of InsP
4
.
Thus, InsP
4
most likely acts via several di¡erent receptor pro-
teins. This is consistent with reports about di¡erent InsP
4
binding proteins in neural and in non-neural tissue. In pig
platelets a 104 kDa InsP
4
receptor protein has been identi¢ed
as a member of the GAPl family [7]. In rat brain, oligomeric
complexes binding InsP
4
and/or InsP
6
have been described [8].
Previously in our laboratory a receptor protein with high
a¤nity for Ins(1,3,4,5)P
4
was solubilized from pig cerebellar
membranes and puri¢ed [9]. The protein was identi¢ed in
SDS-PAGE after photoa¤nity labelling as a 42 kDa protein
band, p42
IP4
[10]. Peptide sequences obtained from this pro-
tein after proteolytic digestion enabled us to develop peptide-
speci¢c antisera [11,12]. One of these antisera directed against
peptide-3 (19 amino acids) recognized the intact receptor pro-
tein in ELISA and in Western blot and immunoprecipitated
the detergent-solubilized InsP
4
receptor protein [12]. In the
present study we report cloning of the cDNA for p42
IP4
from pig brain. The cDNA sequence showed a high homology
to the recently cloned centaurin-K from rat brain [13] and to
several human EST clones. Moreover, we demonstrate that a
42 kDa protein in the cytosolic fraction recognized by the
antiserum is a soluble form of the InsP
4
receptor protein.
For the putative messenger molecule PtdIns(3,4,5)P
3
no
high-a¤nity receptor protein has been found so far. Several
studies had shown that inositol phosphates and phosphoino-
sitide lipids with identical head groups did not bind with
the same a¤nity to the same binding site; examples are the
comparison of Ins(1,4,5)P
3
with PtdIns(4,5)P
2
[14] or
Ins(1,3,4,5)P
4
with PtdIns(3,4,5)P
3
[15,16]. Nevertheless, here
we see that p42
IP4
has identical a¤nities for both ligands. A
homologous protein from rat brain of di¡erent molecular
mass, centaurin-K [13], was described as a PtdInsP
3
binding
protein. Moreover, we report that the membrane-associated
p42
IP4
and the cytosolic form have the same high a¤nity for
PtdInsP
3
and for InsP
4
. Thus, both signaling molecules, InsP
4
and PtdIns(3,4,5)P
3
, might converge in their action on the 42
kDa protein p42
IP4
.
2. Materials and methods
2.1. Binding assays
Membranes were prepared from pig cerebellum in the presence of
protease inhibitors (0.2 mM Pefabloc SC, 1 mM EGTA, 1 Wg/ml
pepstatin, 1 Wg/ml leupeptin, 1 mM benzamidin) as described previ-
ously [12], with the modi¢cation to perform all centrifugation steps at
100 000Ug. The binding assays with fractions obtained during mem-
brane preparation were performed in a ¢nal volume of 400 Wl in
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microcentrifuge tubes. The samples (usually 0.2 mg of protein per
assay) were incubated at 4³C for measurement of (i) InsP
4
binding
activity in a solution containing 0.9^1.2 nM D-[
3
H]Ins(1,3,4,5)P
4
(0.77
TBq/mmol, NEN DuPont, Bad Homburg, Germany; W20 000 dpm),
0.25% BSA, 1 mM EDTA, 25 mM sodium acetate/25 mM potassium
phosphate, pH 5.0, and (ii) of InsP
3
binding activity in the presence of
0.5^0.6 nM D-[
3
H]Ins(1,4,5)P
3
(1.59 TBq/mmol, Amersham,
Braunschweig, Germany; W20 000 dpm), 0.1% BSA, 1 mM EDTA,
and 25 mM TRIS-HCl, pH 9.0. For InsP
4
binding in some experi-
ments, as described in [17] bu¡ers with pH 5.5 and 7.0 or the bu¡er
with pH 7.4 employed by Theibert and coworkers [13] were used.
Nonspeci¢c binding was determined in the presence of 1 WM D-
Ins(1,3,4,5)P
4
(Cell Signal Inc., Kingston, RI) or D-Ins(1,4,5)P
3
(BIO-
MOL, Hamburg, Germany), respectively. The samples were incubated
in the presence of di¡erent concentrations of unlabelled inositolphos-
phates for 20 min. Bound ligand was separated from free ligand by
adding 100 Wl globulin (10 mg/ml) and 500 Wl 5% PEG-8000, further
incubating for 15 min at 4³C and then centrifuging (14 000Ug, 15
min, 4³C). The pellets were washed with 100 Wl of binding bu¡er
and then solubilized with 2% SDS before transferring into scintillation
vials and measuring the bound radioactivity. All determinations made
in duplicate or triplicate showed less than 15% deviations and were
repeated at least twice. For the analysis of the data the RADLIG
computer program (Version 4; BIOSOFT, Cambridge, UK) was
used to estimate K
d
values and the number of binding sites as de-
scribed [17,18].
2.2. Extraction of the InsP
4
receptor from membranes
Aliquots of the membranes prepared from pig cerebellum (5 mg of
each protein) were centrifuged and the pellets were resuspended in 1 ml
of (i) homogenization bu¡er [12], (ii) 100 mM 3-[cyclohexylamino]-1-
propanesulfonic acid (CAPS), pH 11.0, (iii) homogenization bu¡er
supplemented with 1 M NaCl, or (iv) 1% (v/v) mercaptoethanol in
homogenization bu¡er and incubated for 1 h on ice. The samples were
then centrifuged (100 000Ug, 30 min, 4³C) and the supernatants an-
alyzed by Western blotting with the antipeptide antiserum. SDS-
PAGE and immunoblotting were carried out as described [12]. Im-
munoprecipitation of the InsP
4
receptor protein was made as pub-
lished previously [12] using aliquots of the cytosolic fraction (1 mg of
protein).
2.3. Protein sequencing and cDNA cloning
Partial peptide sequences were obtained from protein fragments
after treating p42
IP4
with CNBr [11] (sequences designated CB-n,
underlined in Fig. 1) or with LysC [12] (sequences designated K-m,
underlined in Fig. 1). The peptide sequences CB-1, CB-4, CB-5, K-9
and K-14 were used to design sense and antisense degenerate oligo-
nucleotide primers. These oligonucleotides were employed for PCR
with cDNA synthesized by reverse transcription of total RNA isolated
from pig cerebellum primed with oligo(dT). The PCR conditions were
5 min at 94³C for denaturation, and 35 cycles at 94³C for 1 min, at
50³C for 1.10 min, at 72³C for 1 min for ampli¢cation and 5 min for
¢nal elongation at 74³C. The ampli¢ed products were separated on a
7% polyacrylamide gel; bands were cut out, eluted and cloned into the
pCR-Script cloning vector (Stratagene, Heidelberg, Germany). After
transformation of XL1-blue Escherichia coli cells, clones with insert
were sequenced. PCR clones with sequences corresponding to peptide
sequences were random labelled with [
32
P]dCTP (Amersham) and
used to screen a V gt11 porcine cortex cDNA library (Clontech, Hei-
delberg, Germany). Positive phage plaques were rescreened twice and
¢ve independent single plaques were picked. DNA was isolated ac-
cording to the protocol given by the manufacturer. After size deter-
mination of inserts by restriction digestion inserts were subcloned into
pUC-derivative cloning vector for sequencing. The p42
IP4
cDNA se-
quence from pig brain was con¢rmed by sequencing two independent
overlapping clones on both strands using the dideoxy chain termina-
tion method. Sequence analysis was performed with the software
package of the University of Wisconsin Genetics Computer Group.
3. Results and discussion
Previously in our laboratory we puri¢ed and characterized
the 42 kDa inositol(1,3,4,5) tetrakisphosphate receptor from
pig cerebellum, p42
IP4
[9,10]. The protein was digested with
LysC or with BrCN [11,12]. Degenerate oligonucleotide pri-
mers derived from these peptides were used to generate by
RT-PCR clones using oligo(dT) primed cDNA from pig brain
RNA (clones 1, 2, 3 corresponding to nucleotides 363^736;
648^1003 and 945^1210 in Fig. 1). The resulting cDNA was
employed as a probe to screen a pig brain cDNA library. The
complete nucleotide sequence for p42
IP4
containing the entire
coding region of 1122 bp, sequenced in both directions is
represented in Fig. 1 with the resulting peptide sequence.
The encoded protein of 374 amino acids contains all the se-
quenced cleavage products and has a calculated molecular
mass of 43 kDa, very close to the experimental value of 42
kDa. The excess of basic amino acid residues is consistent
with the chromatographic behaviour of this protein (binding
to cation exchanger at pH 7.0).
The protein sequence of p42
IP4
from pig brain is 84% ho-
mologous to that reported for centaurin-K, a PtdIns(3,4,5)P
3
binding protein from rat brain [13], whereas p42
IP4
is 45 ami-
no acid residues shorter at the C-terminus than centaurin-K.
p42
IP4
shows no distinct hydrophobic domain corresponding
FEBS 18333 24-10-97
Table 1
Pharmacology of D-[
3
H]Ins(1,3,4,5)P
4
binding to membranes and cytosolic fraction from pig cerebellum
InsP
n
Membranes Cytosol
(K
i
þc
n
) (K
i
þc
n
)
D-Ins(1,3,4,5)P
4
1.65þ 0.46 nM 3.82þ 0.84 nM
D/L-Ins(1,3,4,5)P
4
=L/D-Ins(1,3,5,6)P
4
8.86þ 4.99 nM 5.78þ 1.52 nM
D/L-Ins(3,4,5,6)P
4
=L/D-Ins(1,4,5,6)P
4
150.8 þ 56.5 nM 261.0 þ 95.6 nM
Ins(1,3,4,6)P
4
217 þ 30.9 nM 166.2 þ 6.5 nM
D-GroPIP
3
0.91þ 0.11 nM 2.74þ 3 nM
D/L-Ins(1,4,5)P
3
=L/D-Ins(3,5,6)P
3
354.3 þ109.5 nM 194.3 þ 19.6 nM
D-Ins(1,4,5)P
3
=L-Ins(3,5,6)P
3
3.52þ 0.07 WM 5.7 þ 2.2 WM
D/L-Ins(1,5,6)P
3
=L/D-Ins(3,4,5)P
3
17.1 þ 6.9 nM 31.2 þ 1.7 nM
D-Ins(1,2,6)P
3
=L-Ins(2,3,4)P
3
3.31þ 1.43 WM 6.1 þ 1.16 WM
D/L-Ins(1,2,4,5,6)P
5
=L/D-Ins(2,3,4,5,6)P
5
341.0 þ 4.3 nM 564.2 þ 147.8 nM
Ins(1,3,4,5,6)P
5
37.2 þ 13.8 nM 84.7 þ 11.4 nM
D/L-Ins(1,2,3,4,5)P
5
=L/D-Ins(1,2,3,5,6)P
5
18.0 þ 10.9 nM 14.2 þ 1.8 nM
The e¤cacy of D-GroPIP
3
and of various InsP-isomers to displace D-[
3
H]Ins(1,3,4,5)P
4
was tested using the membranes and the cytosolic fraction
from pig cerebellum in the presence of 1.1 nM (in the case of D-GroPIP
3
1.3 nM) D-[
3
H]Ins(1,3,4,5)P
4
in bu¡er pH 5.0. The small amount of
GroPIP
3
available allowed determination of displacement of D-[
3
H]Ins(1,3,4,5)P
4
by this compound in the cytosolic fraction in one experiment only.
Nonspeci¢c binding was determined in all cases at 1 WM D-Ins(1,3,4,5)P
4
. In each experiment the K
i
value was obtained from a displacement curve
testing the compound at 4^8 di¡erent concentrations. For D-Ins(1,3,4,5)P
4
the mean value was derived from 9 (6) experiments for membranes
(cytosol), for the other compounds from 2 to 3 experiments.
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to a putative membrane spanning region. From the 10 ankyr-
in-like repeats in the rat protein we ¢nd eight in p42
IP4
. More-
over, p42
IP4
contains the putative InsP
n
binding protein con-
sensus sequence [13] and most of the consensus amino acids in
ankyrin repeat six (amino acids 259^302), which are homolo-
gous to proteins of the TERM family (talin, ezrin, radixin,
moesin and merlin). Also the hypothesized zinc coordination
site in centaurin-K was detected in p42
IP4
from pig. The func-
tional signi¢cance of these structural motifs has to be clari¢ed.
We further investigated whether p42
IP4
occurs not only in
membranes but also in the cytosol. Using an antipeptide anti-
serum produced against a 19 amino acid peptide (peptide-3
[12] corresponding to K-14 in Fig. 1) derived from peptide
sequencing of fragments of porcine p42
IP4
we were able to
detect this protein in the membrane fraction [12]. This tool
was employed to elucidate whether there is a soluble form
of the Ins(1,3,4,5)P
4
receptor in cerebellum. Therefore we
¢rstly made a comparative analysis of binding of D-
[
3
H]Ins(1,3,4,5)P
4
and D-[
3
H]Ins(1,4,5)P
3
in the fractions of
the membrane preparation and, secondly, we examined the
same fractions by Western blot (Fig. 2). To rule out the pos-
sibility that the results obtained with a soluble fraction were
partly due to contaminating membranes the formerly used
preparation protocol (sedimenting at 35 000Ug) was modi¢ed
by carrying out all centrifugation steps at 100 000Ug.
From the D-[
3
H]Ins(1,3,4,5)P
4
binding activity found in the
tissue homogenate about 25% appeared in the supernatant
from the centrifugation (100 000Ug) whereas the other 75%
were located in the microsomal fraction (Fig. 2Aa-c). Washing
the membranes with bu¡er supplemented with 400 mM NaCl
caused the release of a small amount of Ins(1,3,4,5)P
4
binding
activity from the membranes (Fig. 2Ad) whereas in the follow-
ing low salt washing fractions no D-[
3
H]Ins(1,3,4,5)P
4
binding
was detectable. On the other hand, D-[
3
H]Ins(1,4,5)P
3
binding
activity was found in the membrane fraction (Fig. 2Ac,e,g)
but not in the cytosolic fraction (Fig. 2Ab). Some D-
[
3
H]Ins(1,4,5)P
3
binding activity was detected in the high
salt wash fraction (Fig. 2Ad). It should be noted that the
recovery of D-[
3
H]Ins(1,3,4,5)P
4
binding activity was almost
100%, whereas approximately 50% of the initially determined
D-[
3
H]Ins(1,4,5)P
3
binding activity were lost during membrane
preparation, possibly by inactivation of the binding proteins.
Fig. 2B shows the corresponding Western blot developed by
using the antipeptide antiserum as described earlier [12]. The
42 kDa InsP
4
receptor protein was the prominent protein
band detected in the homogenate (lane 1), the cytosolic frac-
tion (lane 2), the membranes prepared from pig cerebellum
(lane 3), which can be compared with puri¢ed InsP
4
receptor
in lane 4. A protein of 25 kDa which was labelled in the
homogenate (lane 1) was enriched in the cytosolic (lane 2)
and the washing fractions but only a minor constituent of
the membranes (lane 3). Another membrane-associated pro-
tein was recognized at 37 kDa by the antipeptide antiserum in
some preparations as demonstrated previously [12]. Interest-
ingly, only in the cytosol (lane 2) a protein in the high mo-
lecular mass range (s 100 kDa) was labelled with intensities
varying between di¡erent preparations. The nature of this
protein still has to be clari¢ed.
The 42 kDa InsP
4
binding protein appears to some degree
in the fraction obtained by washing the membranes with buf-
fer containing 400 mM NaCl. To investigate the character-
istics of the interaction of p42
IP4
with the membrane, mem-
branes were incubated with (i) homogenization bu¡er (pH 7.7,
control), (ii) 100 mM CAPS, pH 11.0, and homogenization
bu¡er containing (iii) 1 M NaCl or (iv) 1% mercaptoethanol,
and centrifuged. The supernatants were analyzed by Western
blotting with the antipeptide antiserum (Fig. 3). The results
show that the 42 kDa protein is solubilized from the mem-
branes at the basic pH (lane 3) and by the high salt concen-
tration (lane 4) but neither by treatment with the homog-
enization bu¡er (lane 2) nor by the presence of 1%
mercaptoethanol (lane 5). This indicates that the 42 kDa pro-
tein is not an integral membrane protein but a peripheral
membrane protein which is associated with the membrane
by ionic interactions and probably not anchored through co-
valent modi¢cations like attachement of lipids. Interestingly
the 25 kDa protein which was also recognized by the antipep-
tide antiserum was enriched in the pH 11 supernatant (lane 3)
but did not appear in the other supernatants.
The results obtained with Western blotting and analysis of
D-[
3
H]Ins(1,3,4,5)P
4
binding showed that the 42 kDa InsP
4
receptor exists both in a membrane-associated and in a solu-
ble form. To further underpin this conclusion, we tested
whether it was possible to immunoprecipitate the soluble
form of the receptor from the cytosolic fraction with the anti-
peptide antiserum. The Western blot analysis of such an ex-
periment (Fig. 4) shows that the 42 kDa InsP
4
-receptor pro-
tein was immunoprecipitated from the cytosolic fraction by
the antiserum (lane 2). The 25 kDa protein which was also
recognized in the cytosolic fraction (lane 1) was not immuno-
precipitated. Previously we have reported that the antipeptide
antiserum could immunoprecipitate the Ins(1,3,4,5)P
4
receptor
solubilized by detergent treatment of porcine cerebellar mem-
branes and enriched by a following CM-cellulose chromatog-
raphy [12]. Similarly to the experiments using cytosol, the 25
kDa protein is not immunoprecipitated from detergent-solu-
bilized membranes (not shown). The precipitation of the cy-
tosolic 42 kDa InsP
4
-receptor protein was speci¢cally inhib-
ited by preincubation of the antibodies with the peptide used
to generate the antiserum (Fig. 4, lane 3). No protein was
precipitated by the protein A-sepharose in the absence of
the antiserum (lane 4).
Within the cytosol there are di¡erent proteins which can
bind inositolphosphates. A typical example is the report by
Kanematsu et al. [19] of the puri¢cation of two proteins from
the cytosolic fraction of rat brain which bind Ins(1,4,5)P
3
with
high a¤nity (K
d
of 2^5 nM). One of these proteins with a
molecular mass of 85 kDa was identi¢ed as the N1-isozyme of
the phospholipase C [19] and the other as a 130 kDa
Ins(1,4,5)P
3
binding protein homologous to phospholipase
CN-1 [14].
For characterizing the Ins(1,3,4,5)P
4
binding site of the cy-
tosolic fraction we determined the a¤nity for Ins(1,3,4,5)P
4
and for other inositolphosphates and compared these results
with the data obtained for the membrane fraction. Scatchard
analysis of the displacement curves for D-Ins(1,3,4,5)P
4
gave a
K
d
value of 1.65 nM for the microsomal fraction (B
max
: 286
fmol/mg; n=9) and a K
d
value of 3.8 nM for the cytosolic
fraction (B
max
: 386 fmol/mg; n=6). In both cases a two bind-
ing site model can be excluded because it does not ¢t the data
signi¢cantly better than a one binding site model. Heterolo-
gous displacement of D-[
3
H]Ins(l,3,4,5)P
4
by D-Ins(1,4,5)P
3
, D-
Ins(1,2,6)P
3
and Ins(1,3,4,5,6)P
5
showed nearly identical dis-
placement curves for the soluble and the membrane-associated
FEBS 18333 24-10-97
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Ins(1,3,4,5)P
4
receptor (analysis summarized in Table 1). D-
Ins(1,2,6)P
3
, K-trinositol, is an interesting isomer because it is
of potential therapeutic use as an anti-in£ammatory com-
pound [20]. Previously we characterized the binding sites for
K-trinositol in various tissues and compared those with the
Ins(1,3,4,5)P
4
binding sites [17]. Most importantly, the
water-soluble phosphatidyl-inositol(3,4,5) trisphosphate-deriv-
ative D-GroPIP
3
displaced D-[
3
H]Ins(1,3,4,5)P
4
from binding
to the membranes and the cytosolic fraction with an a¤nity
equal to or even slightly higher than that of D-Ins(1,3,4,5)P
4
itself.
We determined binding of [
3
H]InsP
4
to p42
IP4
, either mem-
brane attached or detergent solubilized at various binding
conditions (Fig. 3B): binding in (i) acetate/phosphate bu¡er
at pH 5.0 (see Section 2), or in a bu¡er containing 20 mM
NaCl and 100 mM KCl at (ii) pH 7.0 or (iii) pH 5.5 (as used
in [21], details are published in [17]) is compared with binding
(iv) at pH 7.4 with low salt concentration (25 mM Tris-HCl,
1 mM EDTA, 0.5 mM phosphate and 0.5 mM pyrophos-
phate) as in [13]. We detected the highest InsP
4
binding ac-
tivity in the pH 5.0 bu¡er, whereas both bu¡er (ii) and (iii)
yielded a 50% reduced amount of speci¢c binding at a tracer
concentration of 1.2 nM. At pH 7.0 the K
d
was 42þ 8 nM
(n=3) and B
max
was 3.2 þ 0.5 pmol/mg protein. Thus, the
a¤nity was reduced slightly, 20-fold by the pH change from
5.0 to 7.0. At the low salt conditions, pH 7.4, no InsP
4
bind-
ing could be detected. This is in agreement with the data
reported by Theibert's group, which could not detect binding
of [
3
H]InsP
4
to centaurin-K under these conditions [13,24].
Obviously photoa¤nity labeling with a lipophilic ligand is still
possible under these conditions. Interestingly another InsP
4
binding protein, the GAPl
IP4
investigated by Cullen et al.
from pig platelets displays maximal binding activity at pH
5.5^6.0 (Fig. 1 in [21]). Moreover, InsP
4
binding activity
was maximal at pH 5.0 in canine smooth muscle membranes
[22], as in cerebellar membranes [23]
Previously, using the same experimental conditions de-
scribed here we systematically characterized the binding site
of the puri¢ed InsP
4
receptor by testing all inositol tris-, tet-
rakis-, and pentakisphosphate regioisomers [18]. Some of the
inositolphosphates which are active at the puri¢ed receptor
protein were selected for the present comparative study of
the characteristics of the cytosolic and the membrane-bound
receptor. The analysis in Table 1 revealed that there was no
signi¢cant di¡erence in the K
i
values obtained either with
membranes or with cytosol. The racemic mixture D/L-
FEBS 18333 24-10-97
Fig. 1. Nucleotide sequence and deduced amino acid sequence of cloned cDNA of pig p42
IP4
. (A) The numbers of nucleotides are indicated
along the right margin above the number of the amino acid residue. Underlining of amino acid sequences shows the peptide sequences obtained
by microsequencing of CNBr fragments (CB-1, CB-4, CB-5) or LysC fragments (K-2, K-4, K-6, K-9, K-11, K-14). CB-5 was further con¢rmed
by proteolytic fragments K-7 and K-12. (B) Amino acid sequence alignment of pig p42
IP4
and rat centaurin-K. Gen bank accession number
U88368.
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Ins(1,3,4,5)P
4
displayed 2^6 times lower a¤nity than the ster-
eochemically pure D-isomer. This indicates that the L-isomer is
inactive in displacing D-[
3
H]Ins(1,3,4,5)P
4
from the mem-
brane-associated and the cytosolic receptor. With Ins(1,4,5)P
3
the opposite e¡ect was seen. The racemic mixture D/L-
Ins(1,4,5)P
3
was approximately 10 times more potent than
D-Ins(1,4,5)P
3
in both membranes and cytosol (200^350 nM
versus 3^6 WM, Table 1). This suggests that L-Ins(1,4,5)P
3
is
the displacing agent. It should be noted that L-Ins(1,4,5)P3 is
identical to D-Ins(3,5,6)P
3
. Another interesting InsP
3
-isomer is
the racemic mixture D/L-Ins(1,5,6)P
3
, which is only by a factor
of 10 less potent in inhibiting D-[
3
H]Ins(1,3,4,5)P
4
binding
than the D-Ins(1,3,4,5)P
4
molecule (17.1 and 31.2 nM versus
1.6 and 3.8 nM for the membranes and the cytosolic fraction,
respectively; see Table 1). Since L-Ins(1,5,6)P
3
is identical with
D-Ins(3,4,5)P
3
we conclude from our data that this compound
is the displacing agent but not D-Ins(1,5,6)P
3
. The relative
order of a¤nities of the inositoltetrakisphosphate regioisom-
ers which we have studied in detail with solubilized and pu-
ri¢ed protein [18] is even strikingly similar to the order of
a¤nities reported for a di¡erent InsP
4
binding protein
GAP
IP4
[21], notably determined at di¡erent binding condi-
tions, at pH 7.0.
Within the InsP
5
isomers tested (two enantiomeric pairs and
one mesoform) D/L-Ins(1,2,4,5,6)P
5
was the weakest ligand
(K
i
=341 and 564 nM with the membranes and the cytosolic
fraction, respectively; Table 1) whereas Ins(1,3,4,5,6)P
5
and D/
L-Ins(1,2,3,4,5)P
5
showed only 10^20-fold lower a¤nities than
D-Ins(1,3,4,5)P
4
. It is interesting to note that the a¤nity of the
InsP
4
receptor for Ins(1,3,4,5,6)P
5
increased to values which
were comparable to the K
d
for D-Ins(1,3,4,5)P
4
when the re-
ceptor protein was solubilized with detergent from the mem-
branes [9], whereas the K
i
of the soluble, cytosolic receptor
reported here was as low as that of the membrane-attachted
receptor.
Previously, we observed that a modi¢cation at the 1-posi-
tion (photoa¤nity analogue) of Ins(1,3,4,5)P
4
reduced the af-
¢nity [10]. In this context our present ¢nding is of great im-
portance that the phosphatidylinositol(3,4,5)trisphosphate-
derivative D-GroPIP
3
in which the phosphate group at C-1
of the inositol ring is coupled to glycerol displaced D-
[
3
H]Ins(1,3,4,5)P
4
in membranes with an inhibitory constant
of 0.9 nM and in the cytosolic fraction with 2.7 nM (Table 1).
The same high a¤nity was seen with the InsP
4
receptor pro-
tein puri¢ed from membranes [18]. Therefore it is possible
that this compound is a physiological ligand for the InsP
4
binding protein p42
IP4
. A detailed analysis of physiological
conditions which control ligand binding and a¤nity of
p42
IP4
might give us a clue about the cellular function of
this protein. Binding of the highly phosphorylated ligands
could be a¡ected by salt concentration, in particular, pH (pro-
tonation/deprotonation of the inositololigophosphates or of
charged amino acid residues in the binding protein) or by
additional protein factors possibly interacting in the intact
cell.
Theibert et al. [8,24] used an InsP
4
a¤nity column to isolate
speci¢c high-a¤nity InsP
x
binding proteins from rat cerebellar
membranes. Using the same strategy this group has recently
isolated and cloned another inositolphosphate binding protein
of 46 kDa from rat brain which they called centaurin-K [13].
This protein exists in a membrane-associated and in a soluble
form. Like p42
IP4
, puri¢ed natural centaurin-K has been
shown to bind both PtdIns(3,4,5)P
3
and Ins(1,3,4,5)P
4
. The
di¡erence in a¤nities deduced (IC
50
values of 120 and 620 nM
for PtdInsP
3
and Ins(1,3,4,5)P
4
, respectively) is probably due
to the di¡erent experimental conditions used for the binding
assay. Centaurin-K has a clear selectivity for C-1 and C-3
phosphorylated inositolphosphates compared to other inosi-
tolphosphates tested. Therefore this protein was proposed to
be a high a¤nity PtdInsP
3
binding protein.
The 42 kDa InsP
4
receptor p42
IP4
and centaurin-K are
closely related InsP
4
and PtdInsP
3
binding proteins, with
p42
IP4
being 45 amino acid residues shortened at the C-termi-
nus (Fig. 1B). Centaurin-K identically contains peptide-3 from
the 42 kDa InsP
4
receptor from pig cerebellum which we used
previously for the generation of the antipeptide antisera [12].
Using membranes from di¡erent parts of the rat brain or
retina we found by Western blotting with this antiserum a
protein comigrating in SDS-PAGE with the 42 kDa protein
from pig cerebellum (data not shown). This antiserum, how-
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Fig. 2. Analysis of the fractions obtained during preparation of
membranes from pig cerebellum: (A) binding of D-[
3
H]Ins(1,3,4,5)P
4
and D-[
3
H]Ins(1,4,5)P
3
and (B) distribution of the Ins(1,3,4,5)P
4
-re-
ceptor protein by Western blot. The homogenate from pig cerebel-
lum (Aa; B, lane l) was centrifuged giving the cytosolic fraction
(Ab; B, lane 2) and the pellet (Ac). After removal of the superna-
tant the pellet was resuspended in homogenization bu¡er supple-
mented with 400 mM NaCl and centrifuged again. The resulting
supernatant (Ad) was removed and the pellet (Ae) was washed twice
by resuspension and centrifugation. The supernatants from these
wash steps were pooled (Af), whereas the membrane pellet (Ag; B,
lane 3) was resuspended in homogenization bu¡er. The binding as-
say was carried out in the presence of 1.2 nM D-[
3
H]Ins(1,3,4,5)P
4
or 0.58 nM D-[
3
H]Ins(1,4,5)P
3
and 200 Wg protein per assay (in Af
70 Wg of protein were used) as described in Section 2. After an incu-
bation for 20 min at 4³C bound ligand which was separated from
free ligand was quanti¢ed by measuring radioactivity. In lanes 1^3
in (B) 200 Wg of protein were separated by SDS-PAGE (10% sepa-
ration gel). For comparison in lane 4 puri¢ed Ins(1,3,4,5)P
4
receptor
was applied (W200 ng of protein). After SDS-PAGE followed by
electroblotting to a PVDF-membrane the blot was developed with
antipeptide-antiserum.
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ever, did not detect a protein from rat brain at 46 kDa (cf.
Fig. 4 in [12]).
PtdIns 3-kinase which catalyzes the phosphorylation of in-
ositol phosphate lipids at the 3-position of the inositol ring
[25] is activated by a range of diverse cell surface receptors
such as G-protein-coupled receptors, growth factor and cyto-
kine receptors [26]. PtdIns 3-kinase is a heterodimer of a 85
kDa adaptor subunit (p85) and a 110 kDa catalytic subunit
(p110) ([16] and refs. therein). The p85 regulatory subunit has
several domains exhibiting characteristic homology to pro-
teins involved in signal transduction cascades: a Src homol-
ogy (SH) 3 domain, two SH 2 domains and a region homol-
ogous to the GTPase-activating proteins (GAP) characteristic
for the small GTP binding proteins [26]. In vivo, activation of
PtdIns 3-kinase by various receptors leads to the rapid ap-
pearance of PtdIns(3,4,5)P
3
in cells and this lipid has been
postulated to act as a second messenger conveying informa-
tion from the receptor to yet unidenti¢ed intracelluar targets
[26]. PtdIns 3-kinase can be inhibited speci¢cally by Wort-
mannin. This tool has allowed to identify an important role
for this enzyme and its metabolite in various cell functions
(for review see [27]): these include activation of glucose trans-
port and nerve growth factor stimulated neurite elongation. In
endothelial cells PDGF receptor stimulation causes rearrange-
ment of actin ¢laments resulting in membrane ru¥ing through
activation of PtdIns 3-kinase [28]. The signal is mediated by
activation of the small G-protein Rac by PtdIns(3,4,5)P
3
[29],
thus inducing a selective subset of cellular responses [30].
So far there is hardly any evidence about the nature of the
target proteins of PtdIns(3,4,5)P
3
. The only striking example
known so far is that this lipid speci¢cally interacts with the
SH2 domain of PtdIns 3-kinase thus inhibiting the association
of the kinase with tyrosine-phosphorylated proteins [16]. Since
the 42 kDa protein might be a speci¢c receptor for
PtdIns(3,4,5)P
3
this protein p42
IP4
and Centaurin-K could
play a crucial role in PtdInsP
3
-kinase-dependent signal trans-
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Fig. 4. Immunoprecipitation of the Ins(1,3,4,5)P
4
receptor protein
from the cytosolic fraction analyzed by SDS-PAGE and Western
blot using antipeptide antiserum. Samples of the cytosolic fraction
(lane 1) containing 1 mg of protein each were used for the experi-
ments as described in Section 2 for the precipitation assay (lane 2),
competition by peptide-3 (lane 3) and the control experiment (lane
4), respectively. For comparison the puri¢ed InsP
4
receptor from
pig cerebellar membranes (lane 5, 100 ng of protein) and antipeptide
antiserum (lane 6, 3 Wg of protein) were also subjected to SDS-
PAGE and Western blot. In lane 5 the protein bands detected in
the molecular mass range below 42 kDa result from partial degrada-
tion of the puri¢ed receptor protein.
Fig. 3. Characteristics of p42
IP4
. (A) Extraction of the InsP
4
receptor from membranes. Aliquots of the membranes were treated as described
in Section 2 with homogenization bu¡er (lane 2), 100 mM CAPS, pH 11.0 (lane 3) or homogenization bu¡er containing 1 M NaCl (lane 4) or
1% mercaptoethanol (lane 5). 300 Wl of the resulting supernatants were applied in each lane. In lane 1, 100 ng puri¢ed InsP
4
receptor protein
was loaded on the gel. After SDS-PAGE (12.5% separation gel) the proteins were blotted to a PVDF membrane. The blot was developed with
the antipeptide antiserum [12]. (B) In£uence of pH on InsP
4
binding of p42
IP4
. Speci¢c binding of [
3
H]Ins(1,3,4,5)P
4
(1.2 nM) to membranes
(200 Wg/assay). Bu¡ers with pH 5.0 are described in [23], pH 5.5 and 7.0 in [21,17], pH 7.4 in [13,24]. Data presented are meanþSD from two
separate experiments measured in triplicate.
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duction. Moreover, the comparably high a¤nity of the 42
kDa protein for PtdIns(3,4,5)P
3
and for Ins(1,3,4,5)P
4
makes
it possible that this protein mediates a link between the in-
ositol polyphosphate and the phosphatidylinositol polyphos-
phate signal pathways. The high abundance of the 42 kDa
protein in well-de¢ned brain structures (Kreutz and Reiser,
unpublished) suggests that p42
IP4
is involved in neuron-spe-
ci¢c signalling events. An InsP
4
recognition site was found on
synaptotagmin, a protein involved in Ca
2
dependent vesicle
fusion [31]. Furthermore a block by InsP
4
of the assembly of
the docking particle for synaptic release has been reported
[32]. Thus, InsP
4
might play a role in neuronal plasticity mod-
ulating transmitter release.
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